ICU Medical Q4 2024 revenue up 7% to $629.8M; adj. EPS $2.11 vs $1.57

ICU MEDICAL INC/DE

2024-FY EPS reported -$4.83 revenue$2,382,046,000

Revenue $629.8M (+7% YoY); GAAP gross margin improved to 36.1% from 29.2%.
GAAP net loss $(23.8)M ($(0.97)/share) vs $(17.1)M loss ($(0.71)) in Q4 2023.
Adjusted diluted EPS $2.11 vs $1.57 YoY; Adjusted EBITDA $105.5M vs $86.3M.
Company provided fiscal year 2025 guidance (detailed numbers not in excerpt).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.